Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Targeting PI3K/AKT/mTOR pathway to enhance the anti-leukemia efficacy of venetoclax

PaperCitations, authors & open-access status

Targeting PI3K/AKT/mTOR pathway to enhance the anti-leukemia efficacy of venetoclax is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 18 citations, 2022 year and closed oa status.

18
Citations
2022
Year
closed
OA Status

Related on ScholarIQ

Qingqing Xie
Author
Acute Myeloid Leukemia Research
Topic
Acute Myeloid Leukemia Research
Topic
PI3K/AKT/mTOR signaling in cancer
Topic
Microtubule and mitosis dynamics
Topic
470M+ articles · free account